10-Q Filing

BIO-PATH HOLDINGS, INC. CIK: 1133818 Q3 2015

Filing Information

Form Type	10-Q
Accession Number	`0001144204-15-063740`
Period End Date	20150930
Filing Date	20151109
Fiscal Year	2015
Fiscal Period	Q3
XBRL Instance	bpth-20150930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 68 Income Statement 44 Cash Flow Statement 36

Balance Sheet 68 line items

Line Item	Tag	Value	Unit	Period
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash	`Cash`	$3.55M	USD	Point-in-time
Cash	`Cash`	$13.86M	USD	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash	`Cash`	$9.85M	USD	Point-in-time
Cash	`Cash`	$14.64M	USD	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid drug product for testing	`OtherInventory`	$154.67K	USD	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid drug product for testing	`OtherInventory`	$404.38K	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$100.49K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$200.77K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$10.46M	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$14.11M	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	89.76M	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	89.76M	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	89.76M	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	89.76M	shares	Point-in-time
Furniture, fixtures & equipment	`PropertyPlantAndEquipmentGross`	$123.41K	USD	Point-in-time
Furniture, fixtures & equipment	`PropertyPlantAndEquipmentGross`	$123.41K	USD	Point-in-time
Less Accumulated Depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$41.14K	USD	Point-in-time
Less Accumulated Depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$10.28K	USD	Point-in-time
Property, Plant and Equipment, Net	`PropertyPlantAndEquipmentNet`	$113.13K	USD	Point-in-time
Property, Plant and Equipment, Net	`PropertyPlantAndEquipmentNet`	$82.27K	USD	Point-in-time
Technology licenses	`FiniteLivedLicenseAgreementsGross`	$2.50M	USD	Point-in-time
Technology licenses	`FiniteLivedLicenseAgreementsGross`	$2.50M	USD	Point-in-time
Less Accumulated Amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$1.37M	USD	Point-in-time
Less Accumulated Amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$1.25M	USD	Point-in-time
Intangible Assets, Net (Excluding Goodwill), Total	`IntangibleAssetsNetExcludingGoodwill`	$1.13M	USD	Point-in-time
Intangible Assets, Net (Excluding Goodwill), Total	`IntangibleAssetsNetExcludingGoodwill`	$1.25M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$15.48M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$11.67M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$41.03K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$127.12K	USD	Point-in-time
Accounts payable - related party	`AccountsPayableRelatedPartiesCurrent`	-	USD	Point-in-time
Accounts payable - related party	`AccountsPayableRelatedPartiesCurrent`	$100.45K	USD	Point-in-time
Accrued expense	`AccruedLiabilitiesCurrent`	$253.44K	USD	Point-in-time
Accrued expense	`AccruedLiabilitiesCurrent`	$354.11K	USD	Point-in-time
Accrued expense - related party	`AccruedLiabilitiesRelatedPartiesCurrent`	-	USD	Point-in-time
Accrued expense - related party	`AccruedLiabilitiesRelatedPartiesCurrent`	$67.05K	USD	Point-in-time
Accrued license payments - related party	`DueToRelatedPartiesCurrent`	-	USD	Point-in-time
Accrued license payments - related party	`DueToRelatedPartiesCurrent`	$100.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$481.23K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$561.97K	USD	Point-in-time
Long term debt	`LongTermDebtNoncurrent`	-	USD	Point-in-time
Long term debt	`LongTermDebtNoncurrent`	-	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$561.97K	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$481.23K	USD	Point-in-time
Preferred Stock, $.001 par value 10,000,000 shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred Stock, $.001 par value 10,000,000 shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common Stock, $.001 par value, 200,000,000 shares authorized 89,762,872 and 89,762,872 shares issued and outstanding as of 9/30/15 and 12/31/14, respectively	`CommonStockValue`	$89.76K	USD	Point-in-time
Common Stock, $.001 par value, 200,000,000 shares authorized 89,762,872 and 89,762,872 shares issued and outstanding as of 9/30/15 and 12/31/14, respectively	`CommonStockValue`	$89.76K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$35.03M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$34.74M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-19.92M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-23.93M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$14.92M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$11.19M	USD	Point-in-time
TOTAL LIABILITIES & SHAREHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$11.67M	USD	Point-in-time
TOTAL LIABILITIES & SHAREHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$15.48M	USD	Point-in-time

Income Statement 44 line items

Line Item	Tag	Value	Unit	Period
Revenue	`Revenues`	-	USD	1 Quarter
Revenue	`Revenues`	-	USD	3 Qtrs
Revenue	`Revenues`	-	USD	1 Quarter
Revenue	`Revenues`	-	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$992.45K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$424.52K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.15M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.05M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$519.94K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.85M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$713.35K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.87M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$2.94M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$1.15M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$1.51M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$4.02M	USD	3 Qtrs
Net operating loss	`OperatingIncomeLoss`	$-1.15M	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-2.94M	USD	3 Qtrs
Net operating loss	`OperatingIncomeLoss`	$-4.02M	USD	3 Qtrs
Net operating loss	`OperatingIncomeLoss`	$-1.51M	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$14.44K	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$5.71K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$17.35K	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$4.79K	USD	1 Quarter
Other expense	`OtherNonoperatingExpense`	-	USD	3 Qtrs
Other expense	`OtherNonoperatingExpense`	$14.00	USD	1 Quarter
Other expense	`OtherNonoperatingExpense`	-	USD	1 Quarter
Other expense	`OtherNonoperatingExpense`	$295.00	USD	3 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$5.70K	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$4.79K	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$14.44K	USD	3 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$17.06K	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-2.92M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-4.01M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-1.51M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.15M	USD	1 Quarter
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.03	USD	3 Qtrs
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.04	USD	3 Qtrs
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.01	USD	1 Quarter
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	1 Quarter
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	89.76M	shares	3 Qtrs
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	89.24M	shares	3 Qtrs
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	89.76M	shares	1 Quarter
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	89.24M	shares	1 Quarter

Cash Flow Statement 36 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-2.92M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-4.01M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-1.51M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.15M	USD	1 Quarter
Amortization	`AdjustmentForAmortization`	$120.47K	USD	3 Qtrs
Amortization	`AdjustmentForAmortization`	$120.47K	USD	3 Qtrs
Depreciation	`Depreciation`	-	USD	3 Qtrs
Depreciation	`Depreciation`	$30.85K	USD	3 Qtrs
Stock-based compensation and warrants	`ShareBasedCompensation`	$327.12K	USD	3 Qtrs
Stock-based compensation and warrants	`ShareBasedCompensation`	$283.20K	USD	3 Qtrs
Prepaid drug product for testing	`IncreaseDecreaseInInventories`	$249.71K	USD	3 Qtrs
Prepaid drug product for testing	`IncreaseDecreaseInInventories`	$45.20K	USD	3 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$100.28K	USD	3 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$130.06K	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-80.74K	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-11.74K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-2.66M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-4.00M	USD	3 Qtrs
Purchase furniture, fixtures & equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	3 Qtrs
Purchase furniture, fixtures & equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$66.12K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-66.12K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	-	USD	3 Qtrs
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	3 Qtrs
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$13.81M	USD	3 Qtrs
Net cash from financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$13.81M	USD	3 Qtrs
Net cash from financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	-	USD	3 Qtrs
NET INCREASE (DECREASE) IN CASH	`CashPeriodIncreaseDecrease`	$-4.00M	USD	3 Qtrs
NET INCREASE (DECREASE) IN CASH	`CashPeriodIncreaseDecrease`	$11.08M	USD	3 Qtrs
Cash, beginning of period	`Cash`	$3.55M	USD	Point-in-time
Cash, beginning of period	`Cash`	$13.86M	USD	Point-in-time
Cash, beginning of period	`Cash`	$9.85M	USD	Point-in-time
Cash, beginning of period	`Cash`	$14.64M	USD	Point-in-time
Cash, end of period	`Cash`	$3.55M	USD	Point-in-time
Cash, end of period	`Cash`	$13.86M	USD	Point-in-time
Cash, end of period	`Cash`	$9.85M	USD	Point-in-time
Cash, end of period	`Cash`	$14.64M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.